Annual Secretarial Compliance Report for the year ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genpharmasec Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under SEBI's Listing Regulations. The report was prepared by M/s. Jaymin Modi & Co., Practicing Company Secretaries, and confirms that the company has fully complied with all applicable SEBI regulations, circulars, and guidelines during the review period. No deviations, violations, fines, or penalties were reported. The company also has no outstanding observations from previous reports and no actions have been taken against it, its promoters, directors, or subsidiaries by SEBI or BSE during the year.
This is a routine regulatory filing with no negative findings, which reflects positively on the company's corporate governance and compliance standards. It is unlikely to have any material impact on the stock price but reassures investors about the company's adherence to disclosure norms.